Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.985 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.985 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9776 |
High Similarity |
NPD1549 |
Phase 2 |
0.9265 |
High Similarity |
NPD1510 |
Phase 2 |
0.9254 |
High Similarity |
NPD1240 |
Approved |
0.922 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9197 |
High Similarity |
NPD2796 |
Approved |
0.9172 |
High Similarity |
NPD1934 |
Approved |
0.9118 |
High Similarity |
NPD1607 |
Approved |
0.911 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9048 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8973 |
High Similarity |
NPD7411 |
Suspended |
0.8951 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8926 |
High Similarity |
NPD7075 |
Discontinued |
0.8904 |
High Similarity |
NPD4380 |
Phase 2 |
0.8851 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.88 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD1511 |
Approved |
0.875 |
High Similarity |
NPD6799 |
Approved |
0.8725 |
High Similarity |
NPD7819 |
Suspended |
0.8658 |
High Similarity |
NPD6801 |
Discontinued |
0.863 |
High Similarity |
NPD1512 |
Approved |
0.86 |
High Similarity |
NPD2801 |
Approved |
0.8581 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD6166 |
Phase 2 |
0.8581 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8551 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8542 |
High Similarity |
NPD3750 |
Approved |
0.8523 |
High Similarity |
NPD6599 |
Discontinued |
0.8521 |
High Similarity |
NPD1551 |
Phase 2 |
0.8506 |
High Similarity |
NPD6959 |
Discontinued |
0.8487 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8472 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8433 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8418 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8403 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8366 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8365 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8345 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8322 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8311 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8302 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8301 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.825 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8247 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8207 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8205 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8199 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8188 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8182 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8163 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8162 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8148 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8143 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8134 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8098 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8095 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8079 |
Intermediate Similarity |
NPD920 |
Approved |
0.8069 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.8054 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8041 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8037 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8028 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8014 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8014 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8014 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7975 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7971 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7963 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7949 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7947 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7947 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7947 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7947 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD943 |
Approved |
0.7902 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7902 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7899 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7875 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7853 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.784 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7823 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7801 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7793 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7758 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7742 |
Intermediate Similarity |
NPD3226 |
Approved |
0.774 |
Intermediate Similarity |
NPD1933 |
Approved |
0.774 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7737 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7733 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7733 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD2654 |
Approved |
0.773 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7718 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7688 |
Intermediate Similarity |
NPD919 |
Approved |
0.7682 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7676 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7658 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7639 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7591 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7589 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7589 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7569 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7543 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4288 |
Approved |
0.75 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7448 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7439 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7432 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7415 |
Intermediate Similarity |
NPD411 |
Approved |
0.7415 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7413 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7405 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7386 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7383 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7376 |
Intermediate Similarity |
NPD17 |
Approved |
0.7375 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7365 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7357 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7343 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7318 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7315 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7314 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7312 |
Intermediate Similarity |
NPD5890 |
Approved |
0.731 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD3887 |
Approved |
0.729 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7268 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7255 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7237 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7209 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7209 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7208 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD6280 |
Approved |
0.716 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7134
|
Intermediate Similarity |
NPD7440 |
Discontinued |